These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 36591876)
1. Chilblain-like lesions (COVID-19 toes) have the same impact on family members than psoriasis systemically treated: insights from a case-control study targeting the pediatric population. Damiani G; Finelli R; Kridin K; Pacifico A; Bragazzi NL; Malagoli P; Fabbrocini G; Bonifazi E; Mazzotta F; Lovati C; Savoia P; Gironi LC; Morello M; Davidson T; Watad A; Goker F; Mortellaro C; Del Fabbro M Eur Rev Med Pharmacol Sci; 2022 Dec; 26(3 Suppl):87-93. PubMed ID: 36591876 [TBL] [Abstract][Full Text] [Related]
2. Going viral: A brief history of Chilblain-like skin lesions ("COVID toes") amidst the COVID-19 pandemic. Massey PR; Jones KM Semin Oncol; 2020 Oct; 47(5):330-334. PubMed ID: 32736881 [TBL] [Abstract][Full Text] [Related]
3. Chilblain-like lesions with prominent bullae in a patient with COVID-19. Rubin A; Alamgir M; Rubin J; Rao BK BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33139373 [TBL] [Abstract][Full Text] [Related]
4. Masks trigger facial seborrheic dermatitis and psoriasis: evidence from a multicenter, case-control study during COVID-19 pandemic. Damiani G; Finelli R; Kridin K; Pacifico A; Buja A; Bragazzi NL; Malagoli P; Savoia P; Gironi LC; Grada A; Conic RR; Linder D; Micali G; Pigatto PD; Ital J Dermatol Venerol; 2022 Oct; 157(5):419-423. PubMed ID: 35829673 [TBL] [Abstract][Full Text] [Related]
5. "COVID toes": A meta-analysis of case and observational studies on clinical, histopathological, and laboratory findings. Rocha KO; Zanuncio VV; Freitas BAC; Lima LM Pediatr Dermatol; 2021 Sep; 38(5):1143-1149. PubMed ID: 34515379 [TBL] [Abstract][Full Text] [Related]
6. Chilblain-like lesions onset during SARS-CoV-2 infection in a COVID-19-vaccinated adolescent: case report and review of literature. Paparella R; Tarani L; Properzi E; Costantino F; Saburri C; Lucibello R; Richetta A; Spalice A; Leonardi L Ital J Pediatr; 2022 Jun; 48(1):93. PubMed ID: 35698236 [TBL] [Abstract][Full Text] [Related]
7. Cilostazol as a Treatment for COVID Toes: A Case Report. McClelland P; Gray BH Ann Vasc Surg; 2023 Apr; 91():76-80. PubMed ID: 36442709 [TBL] [Abstract][Full Text] [Related]
8. Chilblain or perniosis-like skin lesions in children during the COVID-19 pandemic: A systematic review of articles. Molaee H; Emadi SN; M Imunya JMN; Davoudi-Monfared E; Mohammed A; Razavi Z Dermatol Ther; 2022 Mar; 35(3):e15298. PubMed ID: 34981615 [TBL] [Abstract][Full Text] [Related]
9. A Review of COVID-19 Chilblains-like Lesions and Their Differential Diagnoses. Sachdeva M; Mufti A; Maliyar K; Lara-Corrales I; Salcido R; Sibbald C Adv Skin Wound Care; 2021 Jul; 34(7):348-354. PubMed ID: 34125725 [TBL] [Abstract][Full Text] [Related]
10. Topical Corticosteroid Concerns Among Parents of Children with Psoriasis versus Atopic Dermatitis: A French Multicenter Cross-Sectional Study. Moawad S; Mahé E; Aubert-Wastiaux H; Phan A; Maruani A; Chiaverini C; Bodemer C; Mazereeuw-Hautier J; Lasek-Duriez A; Droitcourt C; Barbarot S; Beauchet A; Bursztejn AC; Am J Clin Dermatol; 2018 Apr; 19(2):261-265. PubMed ID: 28849428 [TBL] [Abstract][Full Text] [Related]
11. [COVID-toes, a cutaneous sign of innate resistance to SARS-CoV-2]. Yatim A; Gilliet M Rev Med Suisse; 2021 Mar; 17(732):646-652. PubMed ID: 33793103 [TBL] [Abstract][Full Text] [Related]
12. COVID-19 Toes and Other Skin Lesions During the Pandemic: Emerging Entities? Vas PRJ; Georgiadis GS; Papanas N Int J Low Extrem Wounds; 2022 Dec; 21(4):658-660. PubMed ID: 33891517 [TBL] [Abstract][Full Text] [Related]
13. Bilateral Chilblain-like Lesions of the Toes Characterized by Microvascular Remodeling in Adolescents During the COVID-19 Pandemic. Discepolo V; Catzola A; Pierri L; Mascolo M; Della Casa F; Vastarella M; Smith G; Travaglino A; Punziano A; Nappa P; Staibano S; Bruzzese E; Fabbrocini G; Guarino A; Alessio M JAMA Netw Open; 2021 Jun; 4(6):e2111369. PubMed ID: 34110396 [TBL] [Abstract][Full Text] [Related]
14. Pediatric COVID toes and fingers. Koschitzky M; Oyola RR; Lee-Wong M; Abittan B; Silverberg N Clin Dermatol; 2021; 39(1):84-91. PubMed ID: 33972057 [TBL] [Abstract][Full Text] [Related]
15. Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic. Hubiche T; Cardot-Leccia N; Le Duff F; Seitz-Polski B; Giordana P; Chiaverini C; Giordanengo V; Gonfrier G; Raimondi V; Bausset O; Adjtoutah Z; Garnier M; Burel-Vandenbos F; Dadone-Montaudié B; Fassbender V; Palladini A; Courjon J; Mondain V; Contenti J; Dellamonica J; Leftheriotis G; Passeron T JAMA Dermatol; 2021 Feb; 157(2):202-206. PubMed ID: 33237291 [TBL] [Abstract][Full Text] [Related]
16. Evolution of incidence of chilblain-like lesions in children during the first year of COVID-19 pandemic. Bascuas-Arribas M; Andina-Martinez D; Añon-Hidalgo J; Alonso-Cadenas JA; Hernandez-Martin A; Lamagrande-Casanova N; Noguero-Morel L; Mateos-Mayo A; Colmenero-Blanco I; Torrelo A Pediatr Dermatol; 2022 Mar; 39(2):243-249. PubMed ID: 35129855 [TBL] [Abstract][Full Text] [Related]
17. Differences in oxylipin profile in psoriasis versus psoriatic arthritis. Coras R; Kavanaugh A; Kluzniak A; Holt D; Weilgosz A; Aaron A; Quehenberger O; Ritchlin C; Guma M Arthritis Res Ther; 2021 Jul; 23(1):200. PubMed ID: 34303373 [TBL] [Abstract][Full Text] [Related]